Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2018) Vol. 94, Iss. 3, pp. 363-377
Closed Access | Times Cited: 156

Showing 26-50 of 156 citing articles:

Cutaneous Mastocytosis in Childhood—Update from the Literature
Florica Șandru, Răzvan Petca, Monica Costescu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1474-1474
Open Access | Times Cited: 24
Italian Expert Consensus on Clinical and Therapeutic Management of Multiple Chemical Sensitivity (MCS)
Giovanni Damiani, Marco Alessandrini, Daniela Caccamo, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 21, pp. 11294-11294
Open Access | Times Cited: 24
The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review
Roos J. Leguit, Konnie M. Hebeda, Marcus Kremer, et al.
Pathobiology (2019) Vol. 87, Iss. 1, pp. 2-19
Open Access | Times Cited: 28
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis
Anu Gupta, Jarnail Singh, Alfonso García‐Valverde, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 7, pp. 1234-1245
Open Access | Times Cited: 20
SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
Edwige Voisset, Fabienne Brenet, Sophie Lopez, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1996-1996
Open Access | Times Cited: 20
PEDIATRIC MASTOCYTOSIS: AN UPDATE
Fiorina Giona
Mediterranean Journal of Hematology and Infectious Diseases (2021) Vol. 13, Iss. 1, pp. e2021069-e2021069
Open Access | Times Cited: 16
New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019
Michel Arock, Karl Sotlar, Jason Gotlib, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2019) Vol. 61, Iss. 5, pp. 1075-1083
Open Access | Times Cited: 18
Usefulness of Dual X-ray Absorptiometry-Derived Bone Geometry and Structural Indexes in Mastocytosis
Fabio Massimo Ulivieri, Luca Rinaudo, Luca Petruccio Piodi, et al.
Calcified Tissue International (2020) Vol. 107, Iss. 6, pp. 551-558
Closed Access | Times Cited: 18
Mast cell activation syndromes ‑ evaluation of current diagnostic criteria and laboratory tools in clinical practice (Review)
Polliana Mihaela Leru, Vlad Florin Anton, Corina Ureche, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 17
New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood
Justyna Czarny, Monika Żuk, Anton Żawrocki, et al.
Acta Dermato Venereologica (2020) Vol. 100, Iss. 10, pp. adv00149-adv00149
Open Access | Times Cited: 16
Increased group 2 innate lymphoid cells in peripheral blood of adults with mastocytosis
Esmee K. van der Ploeg, Maud A.W. Hermans, Vincent H. J. van der Velden, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 4, pp. 1490-1496.e2
Open Access | Times Cited: 16
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
Calum Slapnicar, Martina Trinkaus, Lisa K. Hicks, et al.
Case Reports in Hematology (2019) Vol. 2019, pp. 1-5
Open Access | Times Cited: 17
Systemic mastocytosis revisited with an emphasis on skeletal manifestations
Antonio Leone, Marianna Criscuolo, Consolato Gullì, et al.
La radiologia medica (2020) Vol. 126, Iss. 4, pp. 585-598
Closed Access | Times Cited: 15
Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis
Nicole Naumann, Johannes Lübke, Sofie Baumann, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2562-2562
Open Access | Times Cited: 14
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
British Journal of Haematology (2021) Vol. 194, Iss. 2, pp. 344-354
Open Access | Times Cited: 14
Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis
Dmitri Atiakshin, Igor Buchwalow, Peter Horny, et al.
Histochemistry and Cell Biology (2021) Vol. 155, Iss. 5, pp. 561-580
Open Access | Times Cited: 13
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis
Simone Marcella, Angelica Petraroli, Mariantonia Braile, et al.
Clinical and Experimental Medicine (2021) Vol. 21, Iss. 3, pp. 415-427
Open Access | Times Cited: 13
Indirect Treatment Comparisons of Avapritinib Versus Midostaurin for Patients with Advanced Systemic Mastocytosis
H. Pilkington, Sarah Smith, Neil Roskell, et al.
Future Oncology (2022) Vol. 18, Iss. 13, pp. 1583-1594
Closed Access | Times Cited: 9
Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
Magda Zanelli, Stefano Ricci, Maurizio Zizzo, et al.
Diagnostics (2021) Vol. 11, Iss. 1, pp. 88-88
Open Access | Times Cited: 12
Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis
Maud A.W. Hermans, Jorn J. Heeringa, Sigrid G.A. Swagemakers, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 1, pp. 146-156.e10
Open Access | Times Cited: 8
Mastocytosis—A Review of Disease Spectrum with Imaging Correlation
Ahmed Elsaiey, Hagar S. Mahmoud, Corey T. Jensen, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5102-5102
Open Access | Times Cited: 11
Systemic diseases affecting the GI tract: A review of clinical and histopathologic manifestations
Maryam Kherad Pezhouh, Dora Lam‐Himlin, Atif Zaheer, et al.
Annals of Diagnostic Pathology (2024) Vol. 73, pp. 152351-152351
Closed Access | Times Cited: 1
Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval
Lillian R. Klug, Christopher L. Corless, Michael C. Heinrich
Journal of Clinical Oncology (2021) Vol. 39, Iss. 15, pp. 1674-1686
Open Access | Times Cited: 10
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF©
Fiona Taylor, Cem Akin, Roger E. Lamoureux, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients
Giulia Carosi, Gregorio Guabello, Matteo Longhi, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 9

Scroll to top